ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis
Atherosclerosis
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis. // Atherosclerosis. – URL: https://www.sciencedirect.com/science/article/pii/S0021915026012931?dgcid=rss_sd_all
ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis. Atherosclerosis. https://www.sciencedirect.com/science/article/pii/S0021915026012931?dgcid=rss_sd_all
“ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis.” Atherosclerosis.
@article{article37197,
title = {ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis},
journal = {Atherosclerosis},
url = {https://www.sciencedirect.com/science/article/pii/S0021915026012931?dgcid=rss_sd_all}
}